Wendy Stock to Real-Time Polymerase Chain Reaction
This is a "connection" page, showing publications Wendy Stock has written about Real-Time Polymerase Chain Reaction.
Connection Strength
0.057
-
Minimal residual disease in acute myeloid leukemia--current status and future perspectives. Curr Hematol Malig Rep. 2015 Jun; 10(2):132-44.
Score: 0.029
-
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia. Oncotarget. 2014 Dec 15; 5(23):12371-82.
Score: 0.028